Cargando…

Accidental Overdose of Paliperidone Palmitate

Long-acting injectable (LAI) antipsychotics first introduced in 1960s are useful in the treatment of schizophrenic patients with poor medication adherence due to their maintaining feature of therapeutic plasma level without daily administration. Paliperidone Palmitate is one of such LAI antipsychoti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ojimba, Chiedozie, Oyelakin, Ayotomide, Khandaker, Taher
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487167/ https://www.ncbi.nlm.nih.gov/pubmed/31110832 http://dx.doi.org/10.1155/2019/7406298

Ejemplares similares

Use of Long-Acting Injectable Antipsychotic in an Inpatient Unit of a Community Teaching Hospital
por: Olayinka, Olaniyi, et al.
Publicado: (2019)

An accidental household outbreak of paliperidone palmitate poisoning via pancake consumption in Lianyungang, China
por: Zhang, Tinglu, et al.
Publicado: (2020)

Manic Symptoms during a Switch from Paliperidone ER to Paliperidone Palmitate in a Patient with Schizophrenia
por: Demirci, Kadir, et al.
Publicado: (2015)

Paliperidone Palmitate-induced Urinary Incontinence: A Case Report
por: Karslıoǧlu, Ersin Hatice, et al.
Publicado: (2016)

Paliperidone palmitate-induced facial angioedema: A case report
por: Srifuengfung, Maytinee, et al.
Publicado: (2020)

Accidental Overdose of Multiple Chemotherapeutic Agents
por: Kim, In Soon, et al.
Publicado: (1989)

A Case of Ileus in a Patient with Schizophrenia Under Paliperidone Palmitate Treatment
por: Can, Serdar Süleyman, et al.
Publicado: (2016)

Differences of use between paliperidone palmitate 3 month and paliperidone palmitate 1 month in real practice, with psychotic patients
por: Escobedo-Aedo, P., et al.
Publicado: (2022)

Paliperidone Palmitate Associated with Necrotizing Deep Tissue Infection and Sepsis Requiring Surgical Intervention
por: Leung, Jonathan G., et al.
Publicado: (2015)

Long-lasting extrapyramidal symptoms after multiple injections of paliperidone palmitate to treat schizophrenia
por: Takada, Ryohei, et al.
Publicado: (2018)

A case report of pregnancy and paliperidone palmitate 3‐monthly long‐acting injection
por: de Azevedo Avelar, Rita, et al.
Publicado: (2020)

Effects of Paliperidone Palmitate on Coagulation: An Experimental Study
por: Yılmaz, Enver Demirel, et al.
Publicado: (2014)

PM394. The outcome of paliperidone palmitate in schizophrenia
por: Ju, Po-Chung
Publicado: (2016)

Hydroxycarbamide overdose: Marrow suppression presenting as neutropenia following accidental overdose: case report
Publicado: (2020)

Accidental staggered paracetamol overdose: An interesting case report
por: Aabideen, Kanakkande, et al.
Publicado: (2011)

Accidental Ixazomib Overdose in a Patient With Multiple Myeloma
por: Sampat, Parth J., et al.
Publicado: (2021)

Bilateral Pretibial Edema Associated with Paliperidone Palmitate Long-acting Injectable: A Case Report
por: Cicek, Erdinc, et al.
Publicado: (2017)

Tachycardia during Treatment with Risperidone and Paliperidone Palmitate in a Patient without Previous Cardiovascular Disease
por: Orlins, Zachary, et al.
Publicado: (2021)

Real-life effectiveness of transitioning from paliperidone palmitate 1-monthly to paliperidone palmitate 3-monthly long-acting injectable formulation
por: Corbeil, Olivier, et al.
Publicado: (2022)

Pharmacoeconomic analysis of paliperidone palmitate for treating schizophrenia in Greece
por: Einarson, Thomas R, et al.
Publicado: (2012)

Paliperidone palmitate-induced enuresis: a case report
por: Cruz, S., et al.
Publicado: (2022)

Prolonged Toxic Encephalopathy following Accidental 4-Aminopyridine Overdose
por: Ballesta Méndez, Maria, et al.
Publicado: (2014)

Cardiac arrest due to accidental overdose with norepinephrine dissolved in crystalloid
por: Hansel, Jan, et al.
Publicado: (2020)

Treatment of concurrent etizolam and tianeptine withdrawal following accidental overdose
por: Markovic, Marija, et al.
Publicado: (2023)

Ivermectin overdose and misuse: Acute encephalopathy due to accidental overdose following drug misuse: case report
Publicado: (2021)

Paliperidone palmitate once‐every‐3‐months in adults with early illness schizophrenia
por: Bell Lynum, Karimah S., et al.
Publicado: (2018)

Paliperidone Palmitate Once-Monthly Injectable Treatment for Acute Exacerbations of Schizoaffective Disorder
por: Fu, Dong-Jing, et al.
Publicado: (2016)

On Neuropsychiatric Manifestations of Basal Ganglia Injury: A Report of Three Cases and Literature Review
por: Azizi, Heela, et al.
Publicado: (2019)

A case report of guardian-consent forced paliperidone palmitate for behavioral disturbance due to traumatic brain injury
por: Douglass, Amber R., et al.
Publicado: (2018)

Five Month-Persistent Extrapyramidal Symptoms following a Single Injection of Paliperidone Palmitate: A Case Report
por: Jang, Seoyoung, et al.
Publicado: (2017)

The use of concurrent long-acting injectable antipsychotic therapy with paliperidone palmitate and aripiprazole monohydrate in a patient with schizophrenia
por: Evernden, Christopher, et al.
Publicado: (2021)

Long-acting injectable paliperidone palmitate induced severe cutaneous allergic reaction in a patient with first episode delusional disorder tolerating oral paliperidone regimen: a case report
por: Borojevic, Natasa, et al.
Publicado: (2022)

Clinical relevance of paliperidone palmitate 3-monthly in treating schizophrenia
por: Mathews, Maju, et al.
Publicado: (2019)

Paliperidone palmitate injection for the acute and maintenance treatment of schizophrenia in adults
por: Kim, Shiyun, et al.
Publicado: (2012)

Paliperidone Palmitate for Schizoaffective Disorder: A Review of the Clinical Evidence
por: Greenberg, William M., et al.
Publicado: (2015)

Alternative initiation regimen of paliperidone palmitate long-acting injectable
por: Menendez Gil, I.E., et al.
Publicado: (2022)

Cost-utility analysis of using paliperidone palmitate in schizophrenia in China
por: Luo, Rui, et al.
Publicado: (2023)

F230. COMPARISON OF PALIPERIDONE PALMITATE 3-MONTH AND PALIPERIDONE PALMITATE 1-MONTH FORMULATION FOR NEGATIVE SYMPTOMS IN SCHIZOPHRENIA: A PHASE 3 NON-INFERIORITY STUDY
por: Mathews, Maju, et al.
Publicado: (2018)

Comparative effectiveness study of paliperidone palmitate 6-month with a real-world external comparator arm of paliperidone palmitate 1-month or 3-month in patients with schizophrenia
por: Turkoz, Ibrahim, et al.
Publicado: (2023)

Predictors of transition from paliperidone palmitate 1 and 3 months (PP1M & PPP3M) to paliperidone palmitate 6 months (PP6M)
por: Escobedo-Aedo, P. J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lbf3le78csjmv6stj5gral5dv9